Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessHighly AccessReview

Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder

Moisés Selman email and Annie Pardo

Instituto Nacional de Enfermedades Respiratorias & Facultad de Ciencias, UNAM, México DF, México

author email corresponding author email

Respiratory Research 2002, 3:3doi:10.1186/rr175

Published: 11 October 2001

Abstract

Idiopathic pulmonary fibrosis is a chronic and usually progressive lung disorder of unknown etiology. A growing body of evidence suggests that, in contrast to other interstitial lung diseases, IPF is a distinct entity in which inflammation is a secondary and non-relevant pathogenic partner. Evidence includes the presence of similar mild/moderate inflammation either in early or late disease, and the lack of response to potent anti-inflammatory therapy. Additionally, it is clear from experimental models and some human diseases that it is possible to have fibrosis without inflammation. An evolving hypothesis proposes that IPF may result from epithelial micro-injuries and abnormal wound healing.


© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.